<DOC>
	<DOCNO>NCT00379522</DOCNO>
	<brief_summary>The purpose present trial therefore ass effect arginine vasopressin vs. saline placebo hospital admission rate ( primary end point ) , well hemodynamic variable , fluid resuscitation requirement hospital discharge rate ( secondary study end point ) presume traumatic hemorrhagic shock patient systolic arterial blood pressure &lt; 90 mm Hg 10 min standard shock treatment . Accordingly , study reflect add-on design standard traumatic shock therapy . The hypothesis arginine vasopressin saline placebo comparable effect hemodynamic variable , fluid resuscitation requirement , hospital admission discharge rate . The alternative hypothesis arginine vasopressin beneficial effect hemodynamic variable , fluid resuscitation requirement , hospital admission discharge rate saline placebo .</brief_summary>
	<brief_title>Vasopressin Traumatic Hemorrhagic Shock Study</brief_title>
	<detailed_description>The study design multicenter , randomize , placebo-controlled clinical trial blind assessment outcome study network helicopter emergency medical service unit Austria , Germany , Switzerland , Italy , Czech Republic Netherlands . The protocol , information consent procedure approve institutional review board participate center . Since study randomize unconscious patient unable give inform consent time randomization ( ยง43a Emergency study ) , requirement inform consent plan waive accordance ethical standard national legislation Germany , Austria , Switzerland , Italy , Czech Republic Netherlands guideline good clinical practice European Agency Evaluation Medicinal product . Depending patient 's outcome , either survive patient , patient 's family case death patient case patient survive remain mentally handicap inform trial ( see appendix patient information sheet ) ; protocol specifies objection , patient withdrawn study . Treatment assignment blind study drug randomly generate computer block two , stratification accord center . Before start trial , staff participate center inform rationale protocol study ; participate center subsequently contact visited ensure proper enrollment .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Hypovolemia</mesh_term>
	<mesh_term>Shock , Hemorrhagic</mesh_term>
	<mesh_term>Arginine Vasopressin</mesh_term>
	<mesh_term>Vasopressins</mesh_term>
	<criteria>Adult trauma patient present presumed traumatic hemorrhagic shock ( systolic arterial blood pressure &lt; 90 mm Hg ) respond first 10 min standard shock treatment [ endotracheal intubation , crystalloid , colloid , hypertonic saline ( 4 ml/kg ) fluid resuscitation , catecholamine ( ephedrine , phenylephrine , norepinephrine , epinephrine ) vasopressor ] . Terminal illness No intravenous access Age &lt; 18 year Injury &gt; 60 min randomization Known pregnancy Cardiac arrest randomization Presence donotresuscitate order Untreated tension pneumothorax Untreated cardiac tamponade Participation another clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>hemorrhagic</keyword>
	<keyword>shock</keyword>
	<keyword>traumatic</keyword>
	<keyword>shock treatment</keyword>
	<keyword>vasopressin</keyword>
	<keyword>Circulatory Collapse</keyword>
	<keyword>Hypovolemic Shock</keyword>
</DOC>